Results 221 to 230 of about 107,794 (297)

Semaglutide 2.4 mg Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States (SMILE)

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6121-6130, July 2026.
ABSTRACT Aims To evaluate the real‐world associations between semaglutide 2.4 mg and cardiometabolic comorbidities, biomarkers and cardiovascular risk among adults with overweight or obesity. Methods This retrospective cohort study used US claims data and laboratory measurements from the Komodo Research Database (2016–2024). Adults with obesity or with
Aleksandrina Ruseva   +11 more
wiley   +1 more source

Ph‐Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs

open access: yesEuropean Journal of Haematology, Volume 117, Issue 1, Page 24-41, July 2026.
ABSTRACT Acute lymphoblastic leukaemia (ALL) in older adults represents a growing clinical challenge, driven by an ageing population, adverse disease biology, and reduced tolerance to intensive chemotherapy. Although pediatric‐inspired regimens have improved outcomes in younger adults with Philadelphia chromosome (Ph)‐negative ALL, survival in older ...
Antonella Bruzzese   +12 more
wiley   +1 more source

STATs Signaling Pathways in Acute Pancreatitis: Mechanisms and Regulation. [PDF]

open access: yesInt J Med Sci
Peng Y   +6 more
europepmc   +1 more source

Liver Injury From Medications Used for Treating Inflammatory Bowel Disease: The Drug‐Induced Liver Injury Network Experience

open access: yesLiver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background We aimed to investigate and characterise DILI due to approved therapies for inflammatory bowel disease (IBD). Methods Using the Drug‐Induced Liver Injury Network (DILIN) prospective study, we evaluated definite, highly likely, or probable DILI attributed to IBD therapies, including use for non‐IBD indications (but excluding ...
Harish Gopalakrishna   +9 more
wiley   +1 more source

Survey on Inter‐ and Intra‐Observer Variations of the Ultrasound Assessment of Dog Pancreases

open access: yesVeterinary Radiology &Ultrasound, Volume 67, Issue 4, July 2026.
ABSTRACT Abdominal ultrasonography (AUS) is considered an important diagnostic tool for assessing pancreatic disease in dogs. However, AUS interpretation is highly subjective and operator‐dependent, with no prior studies evaluating observer variability in assessing the canine pancreas.
R. B. S. Turner   +3 more
wiley   +1 more source

The Predictive Accuracy of Methods Commonly Used for Evaluating Animal Distress

open access: yesThe FASEB Journal, Volume 40, Issue 11, 15 June 2026.
Predictive accuracy of body weight change, distress score, burrowing, and nesting behavior across multiple intervention phases. ABSTRACT Accurate distress assessment is essential for ensuring animal welfare and scientific validity. Although behavioral and physiological indicators are commonly used, their predictive value across disease models and ...
Emily Leitner   +6 more
wiley   +1 more source

Has the Step-Up Approach Improved Prognosis in Severe Necrotizing Acute Pancreatitis? [PDF]

open access: yesJ Clin Med
Gadea-Mateo R   +13 more
europepmc   +1 more source

Novel Genetic Risk Factor Identified for L‐Asparaginase‐Induced Pancreatitis in Pediatric Patients With Cancer

open access: yesPediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
ABSTRACT Background L‐asparaginase is a critical component in treatment protocols for pediatric acute lymphoblastic leukemia. Acute pancreatitis reactions can necessitate delays and, in some cases, discontinuation of L‐asparaginase, which compromises outcomes.
Edward J. Raack   +39 more
wiley   +1 more source

Home - About - Disclaimer - Privacy